BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35762796)

  • 1. Plasma and Intrapulmonary Concentrations of Tebipenem following Oral Administration of Tebipenem Pivoxil Hydrobromide to Healthy Adult Subjects.
    Rodvold KA; Gotfried MH; Gupta V; Ek A; Srivastava P; Talley A; Bruss J
    Antimicrob Agents Chemother; 2022 Jul; 66(7):e0059022. PubMed ID: 35762796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety, Pharmacokinetics, and Food Effect of Tebipenem Pivoxil Hydrobromide after Single and Multiple Ascending Oral Doses in Healthy Adult Subjects.
    Eckburg PB; Jain A; Walpole S; Moore G; Utley L; Manyak E; Dane A; Melnick D
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31262768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrapulmonary Pharmacokinetics of Levonadifloxacin following Oral Administration of Alalevonadifloxacin to Healthy Adult Subjects.
    Rodvold KA; Gotfried MH; Chugh R; Gupta M; Yeole R; Patel A; Bhatia A
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of Oral Tebipenem Pivoxil Hydrobromide in Subjects with Various Degrees of Renal Impairment.
    Patel G; Rodvold KA; Gupta VK; Bruss J; Gasink L; Bajraktari F; Lei Y; Jain A; Srivastava P; Talley AK
    Antimicrob Agents Chemother; 2022 May; 66(5):e0240721. PubMed ID: 35420493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioequivalence of two oral formulations of tebipenem pivoxil hydrobromide in healthy subjects.
    Gupta VK; Patel G; Gasink L; Bajraktari F; Lei Y; Jain A; Srivastava P; Talley AK
    Clin Transl Sci; 2022 Jul; 15(7):1654-1663. PubMed ID: 35411579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of an Antacid (Aluminum Hydroxide/Magnesium Hydroxide/Simethicone) or a Proton Pump Inhibitor (Omeprazole) on the Pharmacokinetics of Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) in Healthy Adult Subjects.
    Patel G; Gupta VK; Gasink L; Bajraktari F; Lei Y; Jain A; Srivastava P; Talley AK
    Antimicrob Agents Chemother; 2023 Apr; 67(4):e0149522. PubMed ID: 36943038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population Pharmacokinetic Analyses for Tebipenem after Oral Administration of Pro-Drug Tebipenem Pivoxil Hydrobromide.
    Ganesan H; Gupta VK; Safir MC; Bhavnani SM; Talley AK; Melnick D; Rubino CM
    Antimicrob Agents Chemother; 2023 Jun; 67(6):e0145122. PubMed ID: 37191505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, Double-Blind, Placebo- and Positive-Controlled Crossover Study of the Effects of Tebipenem Pivoxil Hydrobromide on QT/QTc Intervals in Healthy Subjects.
    Gupta VK; Maier G; Eckburg P; Morelli L; Lei Y; Jain A; Manyak E; Melnick D
    Antimicrob Agents Chemother; 2021 Jun; 65(7):e0014521. PubMed ID: 33875429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Plasma and Intrapulmonary Concentrations of Nafithromycin (WCK 4873) in Healthy Adult Subjects.
    Rodvold KA; Gotfried MH; Chugh R; Gupta M; Friedland HD; Bhatia A
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meropenem-RPX7009 Concentrations in Plasma, Epithelial Lining Fluid, and Alveolar Macrophages of Healthy Adult Subjects.
    Wenzler E; Gotfried MH; Loutit JS; Durso S; Griffith DC; Dudley MN; Rodvold KA
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7232-9. PubMed ID: 26349830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Tebipenem Hydrolysis by β-Lactamases Prevalent in Complicated Urinary Tract Infections.
    Sun Z; Su L; Cotroneo N; Critchley I; Pucci M; Jain A; Palzkill T
    Antimicrob Agents Chemother; 2022 May; 66(5):e0239621. PubMed ID: 35491852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of SPR206 in Plasma, Pulmonary Epithelial Lining Fluid, and Alveolar Macrophages following Intravenous Administration to Healthy Adult Subjects.
    Rodvold KA; Bader J; Bruss JB; Hamed K
    Antimicrob Agents Chemother; 2023 Jul; 67(7):e0042623. PubMed ID: 37338378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption, Metabolism, and Excretion of [
    Gupta VK; Maier G; Gasink L; Ek A; Fudeman M; Srivastava P; Talley A
    Antimicrob Agents Chemother; 2023 Apr; 67(4):e0150922. PubMed ID: 36995239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma and Intrapulmonary Concentrations of ETX2514 and Sulbactam following Intravenous Administration of ETX2514SUL to Healthy Adult Subjects.
    Rodvold KA; Gotfried MH; Isaacs RD; O'Donnell JP; Stone E
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral Tebipenem Pivoxil Hydrobromide in Complicated Urinary Tract Infection.
    Eckburg PB; Muir L; Critchley IA; Walpole S; Kwak H; Phelan AM; Moore G; Jain A; Keutzer T; Dane A; Melnick D; Talley AK
    N Engl J Med; 2022 Apr; 386(14):1327-1338. PubMed ID: 35388666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Omadacycline and Tigecycline Pharmacokinetics in the Plasma, Epithelial Lining Fluid, and Alveolar Cells of Healthy Adult Subjects.
    Gotfried MH; Horn K; Garrity-Ryan L; Villano S; Tzanis E; Chitra S; Manley A; Tanaka SK; Rodvold KA
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and soft-tissue distribution of tebipenem pivoxil hydrobromide using microdialysis: a study in healthy subjects and patients with diabetic foot infections.
    Abouelhassan Y; Fratoni AJ; Shepard AK; Nicolau DP; Asempa TE
    J Antimicrob Chemother; 2022 Dec; 78(1):296-301. PubMed ID: 36424364
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Cotroneo N; Rubio A; Critchley IA; Pillar C; Pucci MJ
    Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32423950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tebipenem pivoxil hydrobromide-No PICC, no problem!
    Sodhi V; Kronsberg KA; Clark M; Cho JC
    Pharmacotherapy; 2021 Sep; 41(9):748-761. PubMed ID: 34370326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamics of Tebipenem: New Options for Oral Treatment of Multidrug-Resistant Gram-Negative Infections.
    McEntee L; Johnson A; Farrington N; Unsworth J; Dane A; Jain A; Cotroneo N; Critchley I; Melnick D; Parr T; Ambrose PG; Das S; Hope W
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31109982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.